empagliflozin, linagliptin, metformin hydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for empagliflozin, linagliptin, metformin hydrochloride, covering 2026-08-11 to 2026-08-11. Get the full timeline:
Most recent: FDA Approved: TRIJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)